KPRX

Kiora Pharmaceuticals (KPRX)

About Kiora Pharmaceuticals (KPRX)

Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Encinitas, CA.

Details

Daily high

$4.00

Daily low

$3.55

Price at open

$3.59

52 Week High

$8.98

52 Week Low

$3.00

Market cap

11.7M

Dividend yield

0.00%

Volume

88,563

Avg. volume

44,577

P/E ratio

-7.30

Kiora Pharmaceuticals News